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ABSTRACT 
 
The Incidence of Tropheryma whipplei  in the Population of  
the Brazos Valley Region of Texas. (December 2008) 
Anna Lavonne Knox, B.S., Texas A&M University 
Co-Chairs of Advisory Committee: Dr. Melanie Ihrig 
 Dr. James Womack 
   
 
An epidemiological study of the bacteria Tropheryma whipplei was conducted in 
the Brazos Valley region of Texas; specifically in the cities of College Station and 
Bryan. DNA samples from the oral cavities of study participants was extracted and 
analyzed for the presence of T. whipplei. Previously published studies have reported 
identifying this bacterium in the saliva of healthy individuals with no signs or symptoms 
of Whipple’s disease.  These investigations were conducted in Europe and Asia, 
including London, England and Switzerland, but data of this nature had yet to be 
obtained within Texas.  After analyzing 147 samples obtained from 49 individuals, no 
indication of T. whipplei existing in the oral cavity of Bryan or College Station residents 
was found. During testing a study was published in May of 2007 indicating that previous 
investigations of this nature had in fact identified different bacteria resulting in false 
positives. 
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CHAPTER I 
INTRODUCTION 
 
The focus of this study was to determine if the bacteria Tropheryma whipplei is 
in the oral cavities of individuals in the Brazos Valley of Texas.  Studies of this nature 
have been done in other parts of the world, but there is no data as to whether T. whipplei 
is present in healthy individuals in this area of the United States. Such a finding would 
provide the basis for T. whipplei and its role in the various forms of the fatal Whipple’s 
disease. 
 This study attempted to determine if Tropheryma whipplei is present in the oral 
cavity: saliva, tartar, and buccal swab, of Brazos Valley residents. 
 Is Tropheryma whipplei present in the oral cavities of healthy people in this area 
of the United States? If the bacterium is present, do specific gender, race, age, and/or 
tobacco habits affect the results? 
Multiple studies have concluded that Tropheryma whipplei can be a normal part 
of the flora of the upper gastrointestinal tract, specifically the oral cavity. Can further 
testing in other geographical areas continue to support the hypothesis that T. whipplei is 
present in the oral cavity of healthy individuals? Although previous studies incorporated 
multiple races, Caucasians have made up the large majority of individuals with oral 
samples positive for T. whipplei. Is this a trend that accurately demonstrates the 
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ratio of Caucasians inhabited with the bacteria to other races? Reportedly males have a 
much higher likelihood of having Whipple’s disease than females. Are males more likely 
to harbor the bacteria than women? If not, are males more susceptible to the colonization 
of T. whipplei in other areas of the body resulting in Whipple’s disease? Does damage to 
the oral cavity from a history of tobacco use increase the possibility of the bacterium 
being present in the oral cavity?   
 It is hypothesized that Tropheryma whipplei will be found in the oral cavity of 
some residents of the Brazos Valley.  
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CHAPTER II 
REVIEW OF LITERATURE 
 
Whipple’s Disease 
 
Tropheryma whipplei is the known causative bacterial agent of Whipple’s 
disease. First described by George Whipple in 1907 as a disease of the intestinal tract 
involving fat metabolism, Whipple’s disease has since been associated with nearly every 
organ system in the human body (1,3,6,13,22). Whipple was a pathologist at Johns 
Hopkins University when a middle-aged male presented with symptoms that had yet to 
be described in medical publications. He referred to the new ailment as intestinal 
lypodystrophy, but the disease name was later changed in his honor.  Whipple’s disease 
has proven to be a more fitting description because intestinal lypodystrophy only 
accounts for a single symptom that infection with T. whipplei can produce (2,13).  The 
disease typically begins with polyarthritis occurring at random times throughout the 
peripheral joints of the body (2,4). Some years later the patient develops other 
characteristic symptoms and the arthritic attacks usually cease at this point. 
Characteristic symptoms include arthritis, fever, diarrhea, weight loss, and 
lymphadenopathy (3,13). Other clinical manifestations may involve the gastrointestinal 
tract (other than diarrhea), the cardiovascular system, the ocular system, and the 
circulatory system, and include skin pigmentation changes (2,4). 
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Symptoms 
The gastrointestinal tract, specifically the small intestinal mucosa, of most 
patients is characterized by a loss of microvilli and the presence of foamy macrophages. 
The loss of microvilli leads to malabsorption and weight loss and the overall change in 
structure leads to excess fat in the stool. Malabsorption results in anemia in up to 90% of 
patients (3).  It was the extracellular deposits of lipids that led Whipple to call the 
disorder “intestinal lypodystrophy” (22). Diarrhea is the most common complaint of 
Whipple’s disease patients. Overall, the intestinal symptoms are not specific and alone 
can be confused with other disorders such as Crohn’s disease, celiac disease, 
amyloidosis, and lymphomas (4).  
Arthritic symptoms occur in at least 90% of patients and are the most common 
non-intestinal manifestations of Whipple’s disease (2,4). Often polyarthritis precedes 
other symptoms by several years and then dissipates when gastrointestinal symptoms 
begin. Transient, migratory pain occurring intermittently between the peripheral joints 
such as knees, elbows, fingers, ankles and shoulders is common (10). 
Cardiovascular involvement unaccompanied by other symptoms is considered 
rare, but does occur. The bacterium can cause pericarditis, myocarditis, systolic 
murmurs, congestive heart failure, and blood-culture negative valvular endocarditis can 
occur (6,8). 
In the original report, Whipple noted a chronic cough associated with a yellowish 
expectoration (22). The cough severity varied with climate and weather and the 
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expectoration was most abundant in the morning. Since that time 30- 40% of patients 
experience this chronic cough sometimes characterized by chest pain and dyspnea (3). 
Central nervous system symptoms rarely occur, but lesions in the brain and 
spinal cord are found in the majority of patients during postmortem examinations (3,14). 
Symptoms associated with this aspect of disease are hypersomnia, memory disturbance, 
facial twitching, and vertical opthalmoplegia (1,14).   
The gastrointestinal symptoms accompanied by arthralgias tend to be 
encompassed as making up the “typical Whipple’s disease” patient. However, there have 
been several documented incidences of people diagnosed with extra-intestinal Whipple’s 
disease where the intestines are not affected. All patients should be treated with extended 
antibiotic regimens, often up to or beyond 1 year of treatment, to rid the body of 
infection and prevent relapse (15). Even after this vigorous treatment there have been 
cases where relapse, especially in the CNS, has occurred involving the exact strain of 
original infection (11). 
 Caucasian males are predominantly affected with an average onset at fifty years 
of age (3).  The male to female ratio is reportedly eight to one (3). There are several 
possible explanations for this distribution. One possibility is a genetic susceptibility to 
the disease which could explain the higher incidence in Caucasians over other races 
and/or the greater incidence in males versus females. Geographic distribution of the 
bacteria is another possible explanation. Worldwide healthcare structures may be the 
most likely explanation due to the years of testing and chronic symptoms associated with 
Whipple’s disease. Worldwide Caucasian males have more opportunity to visit a doctor 
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when symptoms begin.  A diagnosis of Whipple’s disease typically comes after years of 
ruling out other disorders. It is the Caucasian males with money and health insurance 
that can spend those years pursuing the diagnosis.  Due to the years of testing and the 
time between original polyarthritic symptoms and gastrointestinal aspects (or other 
manifestations) of the disease development it may explain why it is not identified until 
middle-age. 
 The Bacterium 
Although the disease was believed to be of bacterial origin for several decades, 
this was not confirmed until 1961 with electron microscopy (24). It was another thirty 
years before the bacterium was named and classified. In 1991 partial 16S rDNA 
sequencing of an isolate from a single infected patient led investigators to label it as the 
Tropheryma whippelii (23). T. whipplei is an actinomycete with a small genome of only 
928 kb, grouped between Cellulomonas  and a rare form actinomycetes with a group B 
peptidoglycan (15,18). 
However, T. whipplei is only distantly related to bacteria in either of those 
classifications further impeding the ability for scientists to make assumptions about the 
function and physiology of this little understood bacterium. Actinomycete bacteria are 
often known to exist in environmental soil, but T. whipplei has not been identified from 
soil samples. Some research has shown a possible link between people who work with 
soil and those who become infected so theories in regards to that have been 
hypothesized. There is a slightly higher prevalence of the disease in farmers than in 
person with other occupations (3). The bacterium is gram positive and though originally 
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thought to be an intracellular obligate, in 2001 it was proven to be a facultative 
intracellular organism (9). The strain Twist-Marseille was isolated from the cardiac 
valve of a Whipple’s disease patient with endocarditis. Fresh HEL cells were inoculated 
with the isolated T. whipplei and allowed to multiply (12). In the cell cultures, T. 
whipplei appeared in an intracellular form and an extracellular form. The intracellular 
form was observed within vacuoles of the infected cells and the extracellular form 
aggregated together and embedded in the extracellular matrix. After analyzing the results 
found in 2001, La Scola et al. corrected whippelii to whipplei by correctly Latinizing 
Whipple to whippleus (12). Tropheryma was derived from trophe ‘nourishment’ and 
eryma ‘barrier’ because by causing malabsorption the bacterium is a barrier to 
nourishment.  
Identification of the Bacterium 
Culture, polymerase chain reaction, and RT-PCR have all successfully been used 
to test for and identify the presence of T. whipplei, but each method has its drawbacks 
(7).   Despite multiple attempts, T. whipplei was not successfully cultured until 2000 
when it was propagated in a human fibroblast cell line (HEL) (18).  The doubling time of 
this bacterium is extremely slow so even if culture becomes easier to set up and 
maintain, it is not an ideal candidate for testing. After the successful culture the entire 
genome of T. whipplei was sequenced allowing further characterization of the bacterium. 
Through this characterization several deficiencies in amino acid biosynthesis and 
synthetic enzyme pathways were noticed suggesting that T. whipplei acquires those 
missing nutrients from the host cells. This information also allowed investigators to 
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better tailor culture media to the bacterium’s needs. In 2003, T. whipplei was cultured in 
cell free media supplemented with 10% fetal calf serum, 1% L-glutamine, and 1% 
human non-essential amino acids (20).  PCR and RT-PCR are much more 
straightforward methods of testing. An animal model has yet to be developed and there 
are a very small number of case studies on animals with Whipple’s-like symptoms. 
Given the difficulty posed by growing the organism, specific and accurate PCR testing is 
ideal. 
Published epidemiological studies in London and Switzerland found T. whipplei 
in the oral cavities of people that were not known or suspected to have Whipple’s 
disease (5,21). These studies analyzed the saliva and plaque of healthy individuals and 
results led investigators to hypothesize that T. whipplei may be part of the normal flora 
of the oral cavity in some individuals (5,21,25). The reported percentages of the 
population that may fall in this category were 33%, 35%  and 50%  (5,21,25).  
Other Studies 
Based on previous data, the Zinkernagel et al. study of 2003 suspected an oral 
habitat for T. whipplei bacteria and they tested saliva, supragingival smooth surface 
plaque, tongue and cheek samples, and samples from gingival pockets to determine if 
these are present in the oral cavity (25).  Three groups of nine to ten systemically healthy 
individuals were tested: University Hospital of Zurich staff volunteers, patients with 
progressive periodontitis, and Chinese subjects that were currently participating in 
another study. Five positive samples in which the bacteria was identified were harvested 
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from the gingival sulcus. All samples of saliva, smooth surface supragingival plaque, 
tongue, and cheek were negative (25). 
The data from Steet et al. contrasted with the results from the previously 
discussed study. Street et al. detected DNA from T. whipplei  in 35% of saliva samples 
taken from healthy volunteers (21).   Of the 40 individuals sampled, 10 male and 4 
female volunteers were positive for the bacteria. All positive individuals except one 
Indian woman were Caucasian. The negative group included 3 Africans, 4 Orientals, 2 
Indo-Asians, and 17 Caucasians. These researchers suggest that T. whipplei is a common 
environmental organism that is not typically pathogenic (21). 
Dutly et al. demonstrated the presence of T. whipplei in duodenal biopsies and/or 
gastric juices of individuals that showed no symptoms of Whipple’s disease (5). This 
study was then followed up by testing the saliva and dental plaques of the 14 individuals 
who were positive in the first study and 17 controls that were negative in the first study. 
Six of the 14 previously positive people had positive saliva samples but no positive 
plaque samples. None of the samples from the control group were positive for the 
bacteria. These researchers concluded that, based on the results of both studies, 
Tropheryma whipplei can reside in both the lower and upper gastrointestinal tract in 
patients with no signs or symptoms of Whipple’s disease (5). 
In May of 2007 Rolain et al. published a study indicating that previous reports of 
T. whipplei in saliva samples were false (19).  This study found that the primer 
sequences used in some previous studies that had a high percentage of positives also 
amplified other strains of actinomycete bacteria. Among those bacteria in one study that 
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found 10 of 57 individuals positive, 8 of those samples contained a 231 bp sequence 
99.1% identical to Actinomyces odontolyticus and 2 yielded a 236 bp sequence 99.6% 
identical to  Actinomyces turicensis (19). Three sequences from another study that found 
3 of 57 individuals positive for T. whipplei yielded a 160 bp sequence that is 98.5% 
identical to Capnocytophaga gingivalis (19).  The results of the 2007 study led Rolain et 
al. to conclude that although asymptomatic carriers may still exist, the prevalence of 
such individuals is much lower than indicated by previous studies (19). 
These previous studies are contradicting, but the ‘false positive’ study was 
published after researchers had finalized the results of the study discussed in this thesis. 
The studies that found T. whipplei in oral cavity samples of a high percentage of 
individuals may have, in fact, been identifying one of the similar bacteria mentioned by 
Rolain et al. However, without further testing of those samples this cannot be confirmed 
and those studies could in fact have positively and accurately identified T. whipplei. 
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CHAPTER III 
METHOD 
 
As discussed in the literature review, the bacterium Tropheryma whipplei has 
been identified in saliva and other oral cavity samples of healthy individuals (5,21,25). 
Research has shown that T. whipplei may be in up to 40% of people that have not been 
diagnosed with or shown symptoms of Whipple’s disease (5).  
This study is modeled after those previously done in hopes of finding T. whipplei 
in the Brazos Valley region of Texas. 
Sample Collection 
The samples were collected at dental offices in Bryan and College Station, 
Texas. Two of the three dentists are located in Bryan, Texas. Bryan’s ethnic makeup is 
50.58% white, 13.84% African American, 21.77% Hispanic or Latino, 0.32% Native 
American, 1.29% Asian, 0.1% Pacific Islander, and 12.12% from other races. The 
remaining dental office was located in College Station, Texas. The demographics of 
College Station, where the third dentist is located, is 82.1% white, 5.6% African 
American, 10.1% Hispanic or Latino, 0.3% Native American, 7.4% Asian, 0.1% Pacific 
Islander, and 4.6% from other races.   
The dental clinics were chosen based on dentists that were members of the 
Brazos Valley Dental Association and willing to assist researchers with sample 
collection and preservation until samples could be picked up by researchers.  These 
dental offices were supplied with all necessary materials for sample collection. 
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  The DNA extraction, polymerase chain reactions, and analyses were performed 
at Texas A&M University College of Veterinary Medicine Research Building and the 
Texas A&M Laboratory Animal Resources and Research Building. 
Participants were required to be between the ages of 40 and 60 years. Based on 
previous studies and the reported demographics of Whipple’s disease, researchers 
believed this age group was the most likely oral source of T. whipplei. The majority of 
people who have been diagnosed with Whipple’s disease have been middle aged. There 
are multiple explanations for this, but in keeping with that trend, individuals in this age 
group were surveyed first. Individuals currently taking antibiotic medications were 
excluded from participation.  The antibiotics would decrease the amount of bacteria 
present in the oral cavity. T. whipplei was expected to be found in extremely low 
amounts potentially resulting in results that were falsely negative; they would have been 
positive had the antibiotics not decreased the amount of bacteria in the mouth. 
People who met the above requirements were asked by the dentist or dental 
hygienist if they were interested in giving samples to be used in the study. Interested 
parties were provided with an informed consent form (Appendix A) supplied by the 
researchers that included an explanation of Whipple’s disease and what participation in 
the study would involve. This form told the patient what samples they were expected to 
provide. It was mentioned that there was no risk to the patient other than what is 
normally encountered at a routine dental visit. Also, the study volunteer would not be 
compensated or receive direct benefit by participating. This consent form was reviewed 
and approved by the Texas A&M University Institutional Review Board (IRB) these 
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were signed by participants and kept on file by the dental office to prevent any 
knowledge of names of participants from the researchers. Individuals had the option to 
back out of the study at any time. 
Along with the informed consent form the participants were asked to fill out a 
short questionnaire (Appendix B). Researchers asked the age, gender, race, and tobacco 
habits of each participant.  Based on the demographics served by the dental offices it 
was expected that a diverse population would be sampled. This would test if the high 
ratio of Caucasians harboring T. whipplei relative to other races was accurate. 
Three Brazos Valley dentists volunteered to collect samples for the study. These 
three offices were provided with pre-assembled, pre-numbered collection kits containing 
the informed consent form, the questionnaire, directions for collection, needed supplies 
for sample collection, and numbered 0.2 ml tubes for sample storage. The informed 
consent form and questionnaire can be found in Appendices A and B.  
To collect the samples from the oral cavity each kit contained one sterile brush 
for the buccal swab (Cyto-Pak CytoSoft Brush, San Marcos, California). Dentists and 
hygienists were asked to use the probe used in regular cleaning for the tartar scrapings. 
These probes are autoclaved by the dental office after each use and were deemed the 
most appropriate instrument for tartar collection by the researchers after discussion with 
dentists. The saliva was collected in cups designed specifically for this purpose by 
Oragene (Genotek, Ontario, Canada). The cups contained a buffer solution that allowed 
for indefinite saliva DNA preservation at room temperature. The cups were filled with 
two milliliters of saliva directly from the mouth. The lid was then applied to the cup and 
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screwed tight to release the buffer and the cup was tipped repeatedly to mix the buffer 
with the saliva. 
The dentists were instructed to collect samples in accordance with the directions 
provided in order to keep all facets of the study as identical as possible decreasing 
variation. For saliva collection dental personnel were asked to have the cup filled to the 
‘full’ line providing two milliliters of saliva. The buccal swab was to be taken from the 
midpoint of the right inner cheek by turning the brush 20 times in one direction. Then 
the brush was to be swirled in the provided cup 20 times in the opposite direction. Using 
a standard dental probe tartar was taken from the first upper premolar on the left side of 
the oral cavity then mixed in the provided tube to remove collected tartar from the probe. 
Along with the cups in the kit were two color coded 0.2 ml tubes containing lysis 
buffer: orange for the buccal swab and clear for the tartar scraping. The color coding was 
to prevent any confusion as to which tube contained which sample. The tubes and the 
Oragene saliva cups were also pre-numbered in correspondence with the informed 
consent form and questionnaire so participants were accurately matched with all three 
samples they provided. 
DNA Extraction 
The saliva DNA was extracted following the Oragene DNA Purification Protocol 
that was provided by Genotek with the sample cups. Genotek also provided all necessary 
reagents except the 95% ethanol, and TE buffer. The protocol gives the option of 
purifying the total four ml sample or a 500 µl aliquot. Researchers chose to purify the 
saliva in aliquots to preserve samples in their original form if re-testing or re-extracting 
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was required. The initial step for any amount of saliva to be purified is incubating the 
Oragene/saliva sample in the Oragene vial at 50°C in a water bath for a minimum of one 
hour. The samples in this study were typically incubated at 50°C over night. This step 
needs only to be performed once so after incubation all vials were marked with an ‘X’ to 
prevent repetitive incubation. 
After incubation 500 µl of Oragene/saliva sample was transferred to a 1.5 ml 
microcentrifuge tube and 20 µl of Oragene Purifier (supplied by manufacturer) was 
added and the tube was inverted at least five times and incubated on ice for 10 minutes. 
Then the sample was centrifuged for 3 minutes at 15,000 x g (13,000 rpm) using a Bio-
Rad microcentrifuge (Bio-Rad, Hercules, California). The clear supernatant was 
transferred via pipet to a clean microcentrifuge tube and the pellet was discarded. To the 
supernatant, 500 µl, of room temperature 95% ethanol was added and the tube was again 
inverted five or more times. This new solution stood at room temperature to allow full 
precipitation of the DNA. At this stage researchers centrifuged tubes for 1 minute at 
15,000 x g (13,000 rpm), but here the supernatant was discarded and the pellet continues 
to the next step. All ethanol was removed from the pellet by air drying before 100 µl of 
TE buffer was added. To fully dissolve the DNA into the solution, the sample was 
vortexed and left to stand over night at room temperature. 
The buccal swab and tartar scraping DNA samples were extracted using the 
Qiagen QIAmp DNA kit following the manufacturer’s procedures as outlined for tissue 
protocol. The tartar and buccal samples were mixed in 200 µl of lysis buffer and this was 
transferred to 1.5 ml microcentrifuge tubes to make room for additional solutions to be 
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added. To this amount 20 µl Proteinase K (provided in kit) was added to this amount and 
mixed by vortex. The samples were placed in an air incubator at 56°C where they were 
constantly rotated over night to assure complete lysing. After overnight lysis, 200 µl of 
Buffer AL (provided in kit) was added followed by 15 seconds of pulse vortexing. Then 
200 µl of 95% ethanol was added, the sample was again mixed by pulse vortex, and was 
left to stand at room temperature for 5 minutes. After 5 minutes the lysate was 
transferred to a Qiagen MinElute column (provided in kit) and centrifuged at 6,000 x g 
(8,000 rpm) for 1 minute. The collection tube was discarded and the MinElute column 
was placed in a clean microcentrifuge tube and 500 µl of Buffer AW1 (provided in kit) 
was added before centrifugation at 6,000 x g (8,000 rpm) for 1 minute. The previous step 
is repeated but 500 µl of Buffer AW2 (provided in kit) is added and the tube is 
centrifuged at 20,000 x g (14,000 rpm) for 3 minutes. The MinElute tube was again 
placed in a clean microcentrifuge tube and 20 µl of distilled water was added before 
incubating the sample at room temperature for 5 minutes and then centrifuging the at full 
speed for 1 minute. 
Standard PCR Amplification 
As a control universal bacterial primers were used. This set of primers was used 
to test the success of the PCR reaction and for the presence of bacteria in each sample to 
demonstrate the success of the DNA extraction.  
Two different sets of Tropheryma whipplei primers were utilized during this 
research. The first set included 4 different primers that were chosen based on those used 
in a previous study by Florence Fenollar (7). They were intergenic spacer primers. The 
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second set of primers was used when results were not clear enough for a definitive 
positive or negative analysis.  These two primers were heat shock protein primers that 
were chosen for the more conservative nature of heat shock proteins over intergenic 
spacer regions. 
All samples were prepared with Taq-Pro Complete Red (Denville Scientific, 
Metuchen, New Jersey) containing 10X PCR 1.5 mM MgCl2, each of the forward and 
reverse primers, and double distilled water. A Bio-Rad thermal cycler (Bio-Rad, 
Hercules, California) was used with conditions set at 94°C for 10 minutes followed by 
40 cycles of 94°C for 30 seconds, 60°C annealing for 30 seconds, and extension at 72°C 
for 30 seconds, and final extension at 72°C for 5 minutes. 
Every reaction that was set up included the sample of interest, sterile water 
(GIBCO, Carlsbad, California) as the negative control, and a positive control of 
Tropheryma whipplei that was acquired from a European laboratory.  
The forward sequence of the universal bacteria primer was (5’ GTT GGC TTA 
GAA GCA GC 3’) and the reverse sequence was (5’ CAT TTT GCC GAG TTC CTT 
3’). 
The first specific T. whipplei primers that were used was a set of four different 
forward and reverse 23S RNA primers labeled SECA, TWT-133, PRO-S, and PRO-184. 
These primers code for intergenic spacer regions.  The forward and reverse sequences 
for SECA are 5’ TTT GTC ATA GGC ATT TCT GTA G 3’ and 5’ AGA CCT CAC 
TGT TAT ACG GAT 3’, respectively. The forward and reverse sequences for TWT-133 
are 5’ GCT GCG CGA AGT AAT TTG 3’ and 5’ AGA TAC ATG CGG AGA TAC T 
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3’, respectively. The forward and reverse sequences for PRO-S are 5’ TCG GAC TAA 
AAG TGC GAC AC 3’ and 5’ GCC TTG ACT ATG ACA TAA TCA A 3’, 
respectively. The forward and reverse sequences for PRO-184 are 5’ ATA ACA AGA 
AGC TGG ATA TGC 3’ and 5’ CGG ATC TTC ACG AAA TGT CC 3’, respectively. 
After several attempts to identify T. whipplei with the intergenic spacer region 
primers results were inconclusive and a switch was made to use heat shock protein 
primers that would be more specific (9).  These primers were developed for a 620 base 
pair sequence. 
 The primer sequences for the heat shock protein were hsp1 Forward (5’ TGA 
CGG GAC AAC ATC TG 3’) and hsp2 Forward (5’ CGC GAA AGA GGT TGA GAC 
TG 3’) with the same reverse sequence; hsp2 Reverse (5’ ACA TCT TCA GCA ATG 
ATA AGA AGT T 3’) (7).   
Results were resolved on 2% agarose gels using 1X TBE buffer made up from a 
pre-mix manufactured by Intermountain Scientific (Intermountain Scientific Corp., 
Kaysville, Utah). This 10X ready pack TBE Buffer mix was diluted in 10 liters of 
double-distilled water to make 1X TBE buffer. Every gel was stained with ethidium 
bromide (AMRESCO, Solon, Ohio) and run in a Bio-Rad electrophoresis chamber for 
varying amounts of time. The gels were then viewed in a fluorescent imaging chamber 
(AlphaInnotech, San Leandro, California) and analyzed by researchers. 
The sensitivity of the standard PCR was determined for each of the three primers 
that were used to analyze all samples: universal bacteria primer, heat shock protein 
primer 1, and heat shock protein primer 2. Serial dilutions were done with the primers 
 19
and tested using the same strain of T. whipplei bacterium that was used as the positive 
control in all PCR runs of samples. The sensitivity of the PCR varied between all 
primers. The universal bacterial primer detected bacteria to 950 pg/µl.  The first heat 
shock protein primer, Hsp1, detected Tropheryma whipplei to 9.5 pg/µl and Hsp2 was 
sensitive to T. whipplei to 0.095 pg/µl.   
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CHAPTER IV 
RESULTS 
 
Analysis of the data collected by the epidemiological survey of Tropheryma 
whipplei is discussed in this chapter. Images of gel electrophoresis that were done by 
researchers were reviewed and data was compiled. All participants were residents of the 
Brazos Valley region of Texas that were in one of the three dental offices for a routine 
teeth cleaning and check up. Their office visits and corresponding sample collections 
took place between November 2005 and August 2006. DNA extraction, PCR 
amplification, and image analysis for results took place between December 2005 and 
October 2007. Samples were taken from fifty volunteers that participated in this study.  
Of the forty-nine volunteers, forty-two were Caucasian, 5 were Hispanic, 1 was 
Asian, and 1 was of Middle Eastern descent. Unfortunately this did not provide as broad 
a spectrum of ethnicity as originally anticipated. The numbers, 85.7% Caucasian, 10.2% 
Hispanic,  2.05% Asian, and 2.05% Middle Eastern did not coincide closely with the 
demographics of the area discussed previously. Nevertheless, should the samples 
collected from these forty-nine volunteers would allow researchers to identify 
Tropheryma whipplei as an oral habitant in the Brazos Valley it would spark further 
research in this area. 
Researchers asked for participants to be between the ages of 40 and 60 years. The 
minimum age was 42 and the maximum age was 61 with a mean of 49 years and 7 
months. 
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The reported ratio of men to women that suffer from Whipple’s disease is eight 
to one (87%). Although these numbers were first reported in 1987 and there is evidence 
to suggest that the difference may not be quite as great as originally reported, there was 
some question whether or not this ratio would prove true if T. whipplei was located in 
Texas (5). The volunteers of this study numbered 15 males and 34 females giving a ratio 
of three to seven male to female. 
Each of the forty-nine participants provided three different samples: the buccal 
swab, the tartar scraping, and the saliva resulting in a total of 147 samples to be tested. 
The DNA extraction from all 147 samples was shown to have been successful by 
positive bands from the universal bacteria primer. When difficulties with reactions arose 
with several samples, the PCR runs were repeated to assure accurate results were 
derived.  
After multiple PCR amplifications of all samples Tropheryma whipplei was not 
identified in any of the 147 samples from 49 individuals of the Brazos Valley Region of 
Texas in an amount greater than could be confirmed by the primers. There were 
occasional faint bands that indicated the possibility of a positive sample, but after those 
suspicious samples were repeatedly re-extracted and re-run, they were conclusively 
determined to be negative.  
The fact that this study failed to identify Tropheryma whipplei in the Brazos 
Valley is not an indication that the bacterium is not present in this region of the world. 
Several factors that may have affected the results of this study and the power of the 
study using the conventional p-value of 0.05 are discussed in detail in Chapter V.  
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
 
This chapter reviews the study. Included are recommendations for improvement. 
Future studies would also test samples using RT PCR in an attempt to identify bacteria 
in amounts below the sensitivity of standard PCR. Another study would also benefit 
from a more diverse and larger population of volunteers. These and other changes would 
make for a more complete epidemiological study of the Brazos Valley region of Texas. 
The purpose of this study was to identify if the bacteria that causes Whipple’s 
disease, Tropheryma whipplei, is present in the oral cavities of healthy residents that are 
not presenting symptoms of Whipple’s disease. 
The results of this study were not in accordance with the hypothesis. It was 
hypothesized that Tropheryma whipplei would be identified in the saliva, tartar, or 
buccal sample of a collection of residents of the Brazos Valley region of Texas. 
There are several explanations for why the proposed hypothesis was not 
supported in this study. The sensitivity of the standard PCR primers that were used may 
have been too low, the small number of resident volunteers (especially males) may have 
contributed, or it is possible that previous studies had false positives.  
The primers hsp1 and hsp2 detected T. whipplei to the 9.5 pg/µl and 0.095 pg/µl 
respectively. Although the likelihood of the bacterium being identified by hsp2 was 
greater than hsp1 there could still have been bacteria present in amounts less than 0.095 
pg/µl. If this study were to be extended, the use of RT-PCR or nested PCR would be 
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necessary. RT-PCR has the capability of identifying smaller amounts of bacteria than 
standard PCR but this high sensitivity can also result in false positives. As this has 
possibly been a problem in previous studies it may not lend itself ideally to the 
identification of T. whipplei.  
Researchers had planned for at least 100 volunteers, but samples from only 49 
individuals were provided.  This number may have yielded better results had there been 
a greater number of males. It has been reported that there is an 8:1 ratio of males: 
females diagnosed with Whipple’s disease. Socioeconomic status and health care 
situations may play a part in this ratio, but if gender is a determining factor this study 
with a male: female ratio of 1:2.267 could likely have affected the results.   
Whipple’s Disease has also heavily affected Caucasians over people of other 
ethnic backgrounds. This study had a high ratio of Caucasian individuals, but it could be 
assumed from previous knowledge that the Asian participant would not harbor the 
bacterium thus lowering the number of possibly positive people to 48 and decreasing the 
sample size by 3. 
Looking back, the survey should have included the profession of those people 
that gave samples. The survey from 1980 of 700 Europeans indicated that farmers and 
carpenters were more likely than people of other professions to have Whipple’s disease. 
One theory on this is that being an actinomycete, T. whipplei is present in the soil and 
natural substances that those professionals frequently are frequently in direct contact.  
Actinomycete bacteria are commonly present in the soil. However, it can be assumed 
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that the amount of farmers and carpenters in the Brazos Valley is such a low number that 
very few if any of the participants are involved in those professions. 
Given that the bacterium in question was not identified in any of the 49 
individuals (147 samples), the Roulain et al. study of 2007 claiming the possibility of 
false positives  can not be over looked. 
When Morgenegg et al. first developed the heat shock protein primer for use in 
detecting T. whipplei, it successfully identified the bacterium in all samples (17) 
previously known to contain the bacterium9a. The 33 negative patient specimens all 
remained negative with this heat shock protein primer after the first 30 cycles and only 3 
of those samples produced weak bands after a further pass of 40 cycles (17). Researchers 
suggested that 2 of those 3 “negative” patient specimens (1 of the 3 specimens was 
diagnosed with Whipple’s disease) may have been false positives. The faint bands in that 
study lend support to this study’s occasional erratic samples that produced faint bands 
upon the first amplification, but were thereafter negative on subsequent tests of the same 
sample. 
The Zinkernagel et al. study found clear cut positive samples from DNA that was 
harvested from the gingival sulcus area. All of the samples in that study taken from 
saliva smooth surface gingival plaque and the cheek were negative. Several reasons have 
been discussed that could explain the lack of T. whipplei in the Brazos Valley, but it 
could be that the bacterium was not actually present in previous studies therefore it is 
more rare than presently believed. If that is the case, it was unlikely that we would have 
located the bacterium in such a small number of samples.  
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The underlying rate of T. whipplei colonization in the oral cavities of people 
living in the Brazos Valley region of Texas is not known.  However we can estimate the 
maximum prevalence that would be statistically consistent with our result of 0 in 49 
trials using a conventional p-value of 0.05. Based on a binomial distribution, an 
estimated underlying T. whipplei prevalence of 1 in 1000 has a 95% chance of giving us 
this same result at the power of 0.9878. 
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APPENDIX A 
 
Texas A&M University 
 
Comparative Medicine Program 
 
Informed Consent Form 
 
Title: Survey of bacterial flora in the oral cavity of peoples ages 40-60 in Brazos Co. 
 
Principal Investigator: Melanie Ihrig 
 
Co-Investigator(s): Robert Rose, Anna Knox 
 
Introduction/Purpose: 
 
You are being asked to volunteer for a research study. The purpose of the study is to 
determine whether a bacterium called Tropheryma whipplei is normally found in the 
mouths of healthy adults in your age group. The presence of this bacterium in the oral 
cavity has not been associated with increased risk of disease.  The information we hope 
to gain from this study will be used to support a request for funding further study of this 
little known bacterium. 
 
We are planning to enroll 500 volunteers between the ages of 40 and 60, from dental 
offices in Brazos County. The reason you are being asked to participate is because you 
have a regular dental exam scheduled.  
 
This document is to provide you with information to consider in deciding whether to 
participate.  Please ask questions if there is anything you do not understand.  You 
participation is voluntary and will have no effect on the quality of you dental care if you 
choose not to participate. 
 
Procedures:  
 
If you agree to participate in the study, saliva, cheek swab, and tartar scrapings will be 
collected by your dentist or dental hygienist during your visit.  These samples will then 
be given to the research investigators so they can be tested to determine if the Troperyma 
whipplei bacteria is present. 
 
Risks: 
There are no known risks associated with collecting saliva samples, cheek swabs, or 
tartar scrapings other than those you would normally experience during a routine oral 
exam. 
 
 31
Benefits: 
 
Being in this study may be of no direct benefit to you, but others may benefit from this 
research. 
 
Alternatives: 
 
If you decide not to participate in this study, you will still receive the standard dental 
care. 
 
Confidentiality: 
 
We will keep your records private.  We will use and ID number rather than your name 
on study records, including the samples that are collected.  The researchers will not have 
a way of linking the ID back to your name and other facts that might point to you.  You 
will not receive your results from this research study. 
 
Compensation and Cost: 
 
Compensation for lost wages or other direct/indirect costs are not available.  You will 
not receive any money for participating in the study.  Your cost will be those incurred 
based on the routine dental visit.  There are no additional costs associated with the study. 
 
Voluntary Participation/Withdrawal: 
 
Your participation in this study is voluntary.  You are free to withdraw your consent at 
any time without the loss of benefits to which you are entitled. 
 
Contact Persons: 
 
If you have any study related questions please contact Melanie Ihrig at 979-845-7433.  If 
you have any questions concerning this research or your rights as a research subject, 
please contact Angelia Raines, Director of the Office of Research Compliance at 979-
847-9362. 
 
Signature: 
 
If you are willing to volunteer for this research, please sign below. 
 
_____________________________  _______ 
Subject’s Signature   Date 
 
_____________________________  _______ 
Person Obtaining Consent  Date 
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APPENDIX B 
 
Survey of Bacterial Flora in the Oral Cavity of Peoples Ages 40-60 in Brazos 
County 
Melanie Ihrig 
Robert Rose 
Anna Knox 
 
Subject # ______ 
 
Age: _______ years 
 
Gender: □ Male □ Female 
 
Ethnicity: Check all that apply. 
 
  □ White of non-Hispanic origin 
  □ African American 
  □ Hispanic 
  □ Asian 
  □ Other ________ 
 
Tobacco User: □ Yes  □ No 
  If yes: 
  □ Cigarettes/Cigars 
  □ Smokeless 
  □ Other________ 
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APPENDIX C 
 
Sample Collection Instructions 
 
1. Saliva- fill to line, screw on cap until mixing buffer is released 
2. Buccal swab- midpoint inner cheek right side, 20 turns with brush, twirl 
brush in tube with buffer 20 times and secure cap on tube. Orange tube 
3. Tartar scrape- 1st upper premolar left side, mix in sample tube with buffer to 
transfer sample from probe, secure cap on tube. Clear tube 
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APPENDIX D 
Subject Age  Gender  Ethnicity  Tobacco Use   
1  42  M   W   N 
2  48  F   W   N 
3  46  F   W   N 
4  50  F   W   Y 
5  53  F   W   N 
6  45  F   W   N 
7  47  F   H   N 
8  42  F   ME   N 
9  58  F   W   Y 
10  61  F   W   N 
11  42  F   W   N 
12  60  M   W   N 
13  42  F   W   N 
14  50  F   W   N 
15  53  F   W   N 
16  44  F   W   N 
17  58  M   W   N 
18  53  F   H   N 
19  51  F   W   N 
20  47  F   H   N 
21  59  F   W   Y 
51  49  F   A   N 
52  45  F   W   N 
53  59  F   W   N 
54  53  M   W   Y 
55  54  F   W   Y 
56  48  F   H   N 
57  55  M   W   N 
58  48  F   W   Y 
81  44  M   W   N 
82   58  M   W   N 
83  53  F   W   Y 
84  50  M   W   N 
85  40  F   W   N 
86  45  F   H   N 
87  49  M   W   N 
88  58  F   W   N 
89  44  F   W   N 
90  53  M   W   N 
91  43  F   W   N 
92  49  F   W   N 
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Subject Age  Gender  Ethnicity  Tobacco Use    
93  51  M   W   N 
94  51  F   W   Y 
95  41  M   W   N 
96  43  M   W   Y 
97  55  F   W   N 
98  40  F   W   N 
99  56  M   W   N 
100  45  F   W   N       
 
_______________________________________________________________________ 
KEY___________________________________________________________________ 
M Male 
F Female 
W Caucasian 
H Hispanic 
A Asian 
ME Middle Eastern 
N No 
Y Yes 
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APPENDIX E 
 
Figure   Samples Tested Successfully 
 
Figure 1  1s  2s  3s  4s  5s  6s  7s  8s  9s 
Figure 2  1t  2t  3t  4t  5t  6t  7t  8t  9t  10t 
Figure 3  11s  11b  11t  12s  12b  12t  14s  14b  14t 
Figure 4  18b  18t  19b  19t  20s  20b  20t  
Figure 5  51s  51t  52s  52t  53s  53t 
Figure 6  51b  52b  53b  100s 
Figure 7  54s  54b  55s  55b  55t  56s  56b  56t 
Figure 8  18s  19s  57s  57b  57t  58s  58b  58t 
Figure 9  83s  83b  83t  84s  84b  84t  85s  85b 
Figure 10  81s  81b  81t  86s  86b  89s  89b  89t 
Figure 11  57s  81s  81t  89s  89b  89t 
Figure 12  87s  87b  87t  91s  91b  91t  96s  96b  96t 
Figure 13  92s  92b  92t  94s  94b  95s  95t 
Figure 14  93s  93b  93t  97s  97b  97t  98b  98t 
Figure 15  82s  82b  82t  88s  88b  88t  99s  99b  99t 
Figure 16  90s  90b  90t  94s 94b  94t  95s  95b  95t 
Figure 17  17b  17t  21b  21t  100s  100b  100t
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